News of the WeekClinical Research

AIDS Vaccine Results Draw Investor Lawsuits

See allHide authors and affiliations

Science  28 Mar 2003:
Vol. 299, Issue 5615, pp. 1965
DOI: 10.1126/science.299.5615.1965b

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

VaxGen, the Brisbane, California, biotech that came under scientific fire last month when it revealed results of the first-ever real-world trial of an AIDS vaccine, is now dodging legal bullets from investors.